» Articles » PMID: 15645995

Low Cost Anti-retroviral Options: Chloroquine Based ARV Regimen Combined with Hydroxyurea and Lamivudine: a New Economical Triple Therapy

Overview
Specialty General Medicine
Date 2005 Jan 14
PMID 15645995
Citations 7
Authors
Affiliations
Soon will be listed here.
Citing Articles

Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?.

Sharma P, McAlinden K, Ghavami S, Deshpande D Eur J Pharmacol. 2021; 897:173928.

PMID: 33545161 PMC: 7857018. DOI: 10.1016/j.ejphar.2021.173928.


Potential specific therapies in COVID-19.

Hamdan Gul M, Htun Z, Shaukat N, Imran M, Khan A Ther Adv Respir Dis. 2020; 14:1753466620926853.

PMID: 32436445 PMC: 7243039. DOI: 10.1177/1753466620926853.


Antiviral activity of chloroquine against dengue virus type 2 replication in Aotus monkeys.

Farias K, Machado P, Muniz J, Imbeloni A, da Fonseca B Viral Immunol. 2015; 28(3):161-9.

PMID: 25664975 PMC: 4390208. DOI: 10.1089/vim.2014.0090.


Complete clearance of cutaneous warts with hydroxychloroquine: antiviral action?.

Bhushan P, Aggarwal A, Baliyan V Indian J Dermatol. 2014; 59(2):211.

PMID: 24700963 PMC: 3969705. DOI: 10.4103/0019-5154.127694.


Development and in vitro evaluation of chloroquine gels as microbicides against HIV-1 infection.

Brouwers J, Vermeire K, Schols D, Augustijns P Virology. 2008; 378(2):306-10.

PMID: 18606432 PMC: 7126913. DOI: 10.1016/j.virol.2008.06.005.